ProUroCare Medical

ProUroCare Medical FCF/Net Income

The Free Cash Flow to Net Income Ratio of ProUroCare Medical (PUMD) as of Nov 21, 2026 is 38.20 %.

FCF/Net Income

38.20 %

Last updated:

Free Cash Flow to Net Income Ratio of ProUroCare Medical is 2012 38.20 % . Free Cash Flow to Net Income Ratio of ProUroCare Medical was 2011 - . It decreases by % lower compared to the previous year.

The ProUroCare Medical FCF/Net Income history

The ProUroCare Medical FCF/Net Income history
YEARFCF/Net IncomeYoY
38.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ProUroCare Medical Stock analysis

What does ProUroCare Medical do? ProUroCare Medical Inc develops the ProUroScan System, a prostate mechanical imaging device for detecting and characterizing male prostate disease. The system uses sensors on a rectal probe, a central processing unit, and software to generate real-time color images of prostate abnormalities detected via digital rectal examination. It provides elasticity imaging, offering non-invasive tissue analysis, and delivers two- and three-dimensional prostate images. The company sells this medical device directly to healthcare providers for diagnostic use. The ProUroScan System is marketed as an adjunctive aid for visualizing prostate abnormalities identified during digital rectal exams. Healthcare providers, including urologists and specialists in prostate health, purchase the device to enhance diagnostic capabilities. The product targets medical facilities requiring advanced imaging solutions for prostate disease detection and characterization. ProUroCare focuses exclusively on the ProUroScan System, with no other products mentioned in the business description. The company’s revenue comes solely from the sale of this imaging system to healthcare professionals and institutions. The device is positioned as a tool for improving diagnostic accuracy in prostate examinations. ProUroCare Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ProUroCare Medical stock

Free Cash Flow to Net Income Ratio of ProUroCare Medical is 38.20 % in 2012.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio ProUroCare Medical since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's ProUroCare Medical with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ProUroCare Medical

All Key Metrics — ProUroCare Medical